News
Lombard Medical’s Endovascular Product Portfolio Presented at Scientific Sessions of the 39th Annual Charing Cross International Symposium
Oxfordshire, UK – May 4, 2017 – Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and
marketer of endovascular aortic aneurysm repair products, today announced that its portfolio of
endovascular stent graft systems, Altura® and Aorfix™, were featured in scientific presentations at the
39th Annual Charing Cross International Symposium in London on April 25 - 26.
Click below to download the full article.
Download
Case Report: EVAR with the ultra low profile Altura Stent Graft System
We started using the Altura Stent Graft System (Lombard Medical) in January 2014, initially in the device first-in-man registry and then in the Elevate multicentre study. We were attracted by the 14F profile and the simplicity of Altura’s concept; two stent grafts that sit side by side in the aorta, extending distally in each common iliac artery, avoiding the need to cannulate a contralateral gate. We also felt the braided construction added flexibility and the potential to dilate stenoses while the woven graft, attached to the outside of the braid at the ends, prevented the braid from overdilating while giving the opportunity for the graft to inflate outside the braid to provide an extended sealing area.
Click below to download the full article.
Download
Evolution Not Revolution: The Altura Stent Graft
Evolution is the gradual, progressive development of an entity that is driven forward by a pressure for change. It often occurs over a prolonged time span, during which some developmental steps improve the entity, but others fail. The effects may be gradual, but the impact of a successful evolutionary change can have profound and long-lasting effects on the status quo of those around them...
Click below to download the full article.
Download